Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dallas, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Forte Biosciences, Inc. has filed 625 SEC EDGAR filings since 16 Nov 2007

SEC filing history

Showing 1-25 of 612 matching filings.

Per page
25
Current page
1
SC TO-C File 005-89959

SC TO-C

Filing date
28 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-89959

SCHEDULE 13G filing

Filing date
28 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-C File 005-89959

SC TO-C

Filing date
27 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-89959

SC14D9C

Filing date
27 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC14D9C File 005-89959

SC14D9C

Filing date
27 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-89959

SCHEDULE 13G/A filing

Filing date
16 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-89959

SCHEDULE 13G/A filing

Filing date
08 Jul 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jul 2026
Reporting date
01 Jul 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jun 2026
Reporting date
16 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Jun 2026
Reporting date
16 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-296425

EFFECT filing

Filing date
10 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-89959

SCHEDULE 13G filing

Filing date
08 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-296425

S-3/A

Filing date
08 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2026
Reporting date
29 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-296425

S-3

Filing date
02 Jun 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2026
Reporting date
29 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2026
Reporting date
29 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2026
Reporting date
29 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2026
Reporting date
29 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Jun 2026
Reporting date
29 May 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .